Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marko Poglitsch

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
European Journal of Clinical Investigation|August 11, 2010
The versatility of HDL: a crucial anti-inflammatory regulatorMarcus D Säemann, Marko Poglitsch, Chantal Kopecky, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 15, 2018
Losartan prevents the elevation of blood pressure in adipose-PRR deficient female mice while elevated circulating sPRR activates the renin-angiotensin systemEva Gatineau, Dianne M Cohn, Marko Poglitsch, et al.
Hypertension (Dallas, Tex. : 1979)|August 28, 2020
Plasma Angiotensin Peptide Profiling and ACE (Angiotensin-Converting Enzyme)-2 Activity in COVID-19 Patients Treated With Pharmacological Blockers of the Renin-Angiotensin SystemUlrich Kintscher, Anna Slagman, Oliver Domenig, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 30, 2020
Associations of central and peripheral blood pressure with the renin-angiotensin-aldosterone system in healthy young adults: the African-PREDICT studyLebo F Gafane-Matemane, Nametsegang L Mokae, Yolandi Breet, et al.
Analytical Chemistry|February 9, 2024
Application of a Biomimetic Nanoparticle-Based Mock Virus to Determine SARS-CoV-2 Neutralizing Antibody Levels in Blood Samples Using a Lateral Flow AssaySilvia Schobesberger, Helena Thumfart, Florian Selinger, et al.
Clinical Pharmacokinetics|May 18, 2013
Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjectsManuel Haschke, Manfred Schuster, Marko Poglitsch, et al.
Hypertension (Dallas, Tex. : 1979)|November 26, 2019
Renin-Angiotensin-Aldosterone System Triple-A Analysis for the Screening of Primary AldosteronismJacopo Burrello, Fabrizio Buffolo, Oliver Domenig, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 14, 2017
Can Screening and Confirmatory Testing in the Management of Patients with Primary Aldosteronism be Improved?Michael Stowasser, Ashraf Ahmed, Zeng Guo, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 5, 2021
Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory StudyJohannes J Kovarik, Christopher C Kaltenecker, Oliver Domenig, et al.
Cardiovascular Journal of Africa|November 30, 2019
A primary aldosteronism-like phenotype identified with the aldosterone-to-angiotensin II ratio in black men: the SABPA studyJohannes M van Rooyen, Marko Poglitsch, Hugo W Huisman, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
European Journal of Clinical Investigation|August 11, 2010
The versatility of HDL: a crucial anti-inflammatory regulatorMarcus D Säemann, Marko Poglitsch, Chantal Kopecky, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 15, 2018
Losartan prevents the elevation of blood pressure in adipose-PRR deficient female mice while elevated circulating sPRR activates the renin-angiotensin systemEva Gatineau, Dianne M Cohn, Marko Poglitsch, et al.
Hypertension (Dallas, Tex. : 1979)|August 28, 2020
Plasma Angiotensin Peptide Profiling and ACE (Angiotensin-Converting Enzyme)-2 Activity in COVID-19 Patients Treated With Pharmacological Blockers of the Renin-Angiotensin SystemUlrich Kintscher, Anna Slagman, Oliver Domenig, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 30, 2020
Associations of central and peripheral blood pressure with the renin-angiotensin-aldosterone system in healthy young adults: the African-PREDICT studyLebo F Gafane-Matemane, Nametsegang L Mokae, Yolandi Breet, et al.
Analytical Chemistry|February 9, 2024
Application of a Biomimetic Nanoparticle-Based Mock Virus to Determine SARS-CoV-2 Neutralizing Antibody Levels in Blood Samples Using a Lateral Flow AssaySilvia Schobesberger, Helena Thumfart, Florian Selinger, et al.
Clinical Pharmacokinetics|May 18, 2013
Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjectsManuel Haschke, Manfred Schuster, Marko Poglitsch, et al.
Hypertension (Dallas, Tex. : 1979)|November 26, 2019
Renin-Angiotensin-Aldosterone System Triple-A Analysis for the Screening of Primary AldosteronismJacopo Burrello, Fabrizio Buffolo, Oliver Domenig, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 14, 2017
Can Screening and Confirmatory Testing in the Management of Patients with Primary Aldosteronism be Improved?Michael Stowasser, Ashraf Ahmed, Zeng Guo, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 5, 2021
Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory StudyJohannes J Kovarik, Christopher C Kaltenecker, Oliver Domenig, et al.
Cardiovascular Journal of Africa|November 30, 2019
A primary aldosteronism-like phenotype identified with the aldosterone-to-angiotensin II ratio in black men: the SABPA studyJohannes M van Rooyen, Marko Poglitsch, Hugo W Huisman, et al.
Pageof 10